Anthem Biosciences receives the highest institutional bids for a ₹1,000 crore-plus IPO in 2025

Anthem Biosciences IPO received bids for 281.45 crore shares, in comparison to 4.40 crore shares on offer. The IPO, which opened for subscription on July 14 in the primary market, got fully subscribed on the second day of the bidding process.

Leave a Reply

Your email address will not be published. Required fields are marked *